GLSI

NASDAQ · Biotechnology

Greenwich Lifesciences Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$26.81

+1.13 (+4.40%)

As of Mar 25, 3:05 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +27.0% upside

Low Target $25.54

Average Target $34.05

High Target $45.13

Current Price $26.81

Current
$26.81

Target
$34.05

$25.54 $34.05 avg $45.13

Scenario Analysis

Bear Case

$25.54

-4.7%

Low target

Base Case

$34.05

+27.0%

Avg target

Bull Case

$45.13

+68.3%

High target

Risk/Reward

14.4x

Highly favorable

Price in Context

52-Week High

$34.10

-21.4% from high

52-Week Low

$7.78

+244.6% from low

Target vs 52W High

$34.05

-0.1% vs high

Next Earnings Report

Apr 13, 2026

17d

until earnings

EPS Est: $-0.33

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%